Clinical trial · Observational
Post Approval Commitment Study
A Non-Interventional Post Approval Commitment Study To Evaluate The Outcomes Of The Various Treatment Options For Dupuytren's Contracture
NCT01444729CI-TRIAL-00030058completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
An agreement has been made to conduct a post-approval commitment study that provides supplementary information relating to the use of Xiapex® as well as other non-pharmacological treatments for Dupuytren's contracture by health care professionals in a real world clinical setting.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Dupuytren's Contracture | Palmar Fibromatosis | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| surgery | Procedure | — | UNRESOLVED |
| Xiapex | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- xiapex
- description
- Subject treated with Xiapex
- interventionNames
- Drug: Xiapex
- label
- Surgery
- description
- Fasciotomy or fasciectomy
- interventionNames
- Procedure: surgery
Primary outcomes (2)
- measure
- clinical treatment success as assessed by goniometry
- timeFrame
- an expected average of 5 weeks
- measure
- treatment satisfaction using the Patient or Physician Global Assessment and Satisfaction questionnaires
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults with a palpable cord eligible for the treatment of Dupuytren's contracture Exclusion Criteria: none
References
Publications (0)
Data not yet available
No reference posted for this study.